Moxonitex, 0.2 mg 28 pcs.

Hypertension (high blood pressure)- arterial hypertension.

Indications

– arterial hypertension.

Pharmacological effect

Selective agonist of imidazoline receptors.

Special instructions

During treatment, regular monitoring of blood pressure, heart rate and ECG is required. If it is necessary to cancel simultaneously taken beta-blockers and the drug Moxonitex, beta-blockers are canceled first and only after a few days – Moxonitex.

Active ingredient

Moxonidine

Composition

active substance:

Pregnancy

There have been no reliable studies of the use of moxonidine in pregnant women.

Contraindications

– hereditary lactose intolerance, lactase deficiency or glucose-galactose malabsorption;

Side Effects

According to WHO, side effects are classified according to their frequency as follows: often (>1/100, 1/1000, 1/10,000, <1/1000) and very rarely (<1/10,000), including isolated reports.

Interaction

Concomitant use of moxonidine with other antihypertensive drugs leads to an additive effect.

Overdose

Symptoms: headache, marked decrease in blood pressure, bradycardia, palpitations, weakness, drowsiness, dry oral mucosa; rarely – vomiting and epigastric pain. Paradoxical arterial hypertension and hyperglycemia are potentially possible.

Recommendations for use

Moxonitex is prescribed orally, regardless of food intake, with a sufficient amount of liquid. The dosage regimen is selected individually. The initial dose is 200 mcg in the morning.

Storage conditions

The drug should be stored out of reach of children at a temperature not exceeding 25°C

Shelf life

2 years

Manufacturer

Salutas Pharma GmbH, Germany